Cattle: Treatment of hypersensitivity of bovine respiratory disease (BRD) associated with Mannheimia haemolytica, Pasteurella multocida, Histophilus somni and Mycoplasma bovis sensitive to tulathromycin. The occurrence of disease in the herd should be established prior to metaphylactic treatment. Treatment of Infectious bovine keratoconjunctivitis (IBK) in combination with Moraxella bovis sensitive to tulathromycin

Swine: Treatment of hypersensitivity of swine respiratory disease (SRD) associated with tulathromycin-sensitive Actinobacillus pleuropneumoniae, Pasteurella multocida, Mycoplasma hyopneumoniae, Haemophilus parasuis and Bordetella bronchiseptica are sensitive to tulathromycin. The occurrence of disease in the herd should be established prior to metaphylactic treatment. Should only be used if swine are expected to develop the disease within 2 – 3 days

Sheep: Treat the early stages of subcutaneous inflammation (Interdigital necrobacillosis) associated with toxic Dichelobacter nodosus requiring systemic treatment

Cattle: Single dose subcutaneously, 1 ml per 40 kg of body weight. Cattle over 300 kg, divide injection not exceeding 7.5 ml at 1 site

Swine: Intramuscular injection 1 single dose, 1 ml per 40 kg of body weight. Swine over 80 kg divide injection not exceeding 2 ml at 1 site

Sheep: Single dose intramuscular injection, 1 ml per 40 kg of body weight

Note:

The drug should be used as soon as the animal shows signs of pneumonia

Do not inject more than 2.5 ml for swine and 7.5 ml for cattle per injection site

Do not administer to animals hypersensitive to macrolides

Do not use the drug together with antibiotics of the same group of macrolides or antibiotics of the Lincosamide group

For meat:

Cow: 22 days

Swine: 13 days

Sheep: 16 days

Store in a cool, dry place, away from direct sunlight, at temperature not exceeding 30^oC

20 ML, 50 ML, 100 ML